IntriCon Co. (IIN) Shares Bought by Barclays PLC

Barclays PLC lifted its position in shares of IntriCon Co. (NASDAQ:IIN) by 869.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 26,990 shares of the technology company’s stock after purchasing an additional 24,206 shares during the quarter. Barclays PLC owned about 0.31% of IntriCon worth $712,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of IIN. MetLife Investment Advisors LLC acquired a new position in shares of IntriCon in the 3rd quarter valued at approximately $295,000. Shell Asset Management Co. acquired a new stake in shares of IntriCon during the 3rd quarter valued at approximately $310,000. Sun Life Financial INC acquired a new stake in shares of IntriCon during the 4th quarter valued at approximately $155,000. Russell Investments Group Ltd. acquired a new stake in shares of IntriCon during the 3rd quarter valued at approximately $348,000. Finally, Alliancebernstein L.P. bought a new position in IntriCon during the 3rd quarter worth $393,000. Institutional investors and hedge funds own 64.83% of the company’s stock.

IIN has been the subject of a number of recent research reports. ValuEngine downgraded IntriCon from a “buy” rating to a “hold” rating in a research note on Monday, March 11th. Dougherty & Co raised IntriCon from a “neutral” rating to a “buy” rating and set a $44.00 price target for the company in a research note on Thursday, January 3rd. Stifel Nicolaus decreased their price target on IntriCon from $70.00 to $45.00 and set a “buy” rating for the company in a research note on Friday, January 4th. Finally, Zacks Investment Research cut IntriCon from a “buy” rating to a “hold” rating in a research note on Friday, January 4th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $50.25.

In other IntriCon news, VP Greg Gruenhagen sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $25.33, for a total value of $37,995.00. Following the completion of the sale, the vice president now owns 4,047 shares in the company, valued at approximately $102,510.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold a total of 7,500 shares of company stock valued at $198,225 in the last quarter. Corporate insiders own 11.50% of the company’s stock.

Shares of IIN traded up $0.18 during midday trading on Friday, reaching $26.02. 89,125 shares of the stock were exchanged, compared to its average volume of 156,977. IntriCon Co. has a 12-month low of $20.95 and a 12-month high of $76.80. The company has a market capitalization of $226.58 million, a PE ratio of 40.66, a price-to-earnings-growth ratio of 3.27 and a beta of 1.21.

IntriCon (NASDAQ:IIN) last issued its quarterly earnings data on Tuesday, February 19th. The technology company reported $0.09 EPS for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.07). The company had revenue of $30.81 million for the quarter, compared to analyst estimates of $30.30 million. IntriCon had a net margin of 4.76% and a return on equity of 9.63%. Equities analysts forecast that IntriCon Co. will post 0.66 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “IntriCon Co. (IIN) Shares Bought by Barclays PLC” was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at

IntriCon Company Profile

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.

Featured Article: Do back-end load funds outperform no-load funds?

Institutional Ownership by Quarter for IntriCon (NASDAQ:IIN)

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with's FREE daily email newsletter.